Stay updated on IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Sign up to get notified when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.
Latest website image capture
Clouds background image

Latest updates to the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page

  1. Check
    4 days ago
    Change Detected
    Summary
    Taiwan site entry updated in the locations list: Taoyuan, Taiwan, 333 was removed and Taoyuan County, Taiwan, 333 was added. This reflects a site name adjustment in the same region.
    Difference
    0.0%
    Check dated 2026-05-06T02:40:39.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.3, was added to the page, replacing the previous v3.5.2. This reflects an updated version or patch release being recorded as the current revision.
    Difference
    0.0%
    Check dated 2026-04-28T22:31:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s displayed revision/version has been updated from **v3.5.0** to **v3.5.2**.
    Difference
    0.0%
    Check dated 2026-04-21T15:58:58.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Location entry updated to Padova, Veneto, Italy (35128), replacing Padua for the site.
    Difference
    0.0%
    Check dated 2026-04-07T03:03:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.4.3 to v3.5.0. No substantive study content changes are indicated.
    Difference
    0.0%
    Check dated 2026-03-23T17:27:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a topic. Included a Resources section with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-03-16T18:01:02.000Z thumbnail image

Stay in the know with updates to IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Enter your email address, and we'll notify you when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.